Bladder Cancer

Comorbid Illnesses Worsen Post-Cystectomy Outcomes

February 01, 2012

Greater comorbid illness increases the likelihood of complications after radical cystectomy for bladder cancer among patients older than 70 years, according to German researchers.
 

Smaller Bladder Tumors Less Like to Recur After Surgery

December 10, 2011

Non-muscle-invasive bladder tumors 15 mm or less in diameter are associated with a lower risk of recurrence after surgical treatment compared with larger tumors, according to researchers.
 

Extended LND Improves Outcomes in Selected Bladder Cancer Patients

November 28, 2011

Extended lymph node dissection (LND) does not significantly change overall disease recurrence and survival patterns in patients who undergo radical cystectomy for bladder cancer compared with limited LND, but certain patient subgroups experience improvements in these outcomes, a study found.
 

Diabetes Increases Bladder Ca Recurrence, Progression Risk

November 21, 2011

Diabetes mellitus (DM) appears to be an independent predictor of disease recurrence and progression among patients with non-muscle invasive bladder cancer (NMIBC), according to investigators.
 

Neutrophil/Lymphocyte Ratio Can Upstage Bladder Cancer Patients Prior to Surgery

November 04, 2011

SAN FRANCISCO—Prior to radical cystectomy for bladder cancer, preoperative neutrophil/lymphocyte ratio (NLR) can identify patients at risk for having non-organ-confined disease and who may benefit from neoadjuvant chemotherapy, University of Wisconsin investigators reported at the American College of Surgeons 97th Clinical Congress.
 

Cancer Risk Higher in Transplant Recipients

November 02, 2011

Infection-related and unrelated cancers develop more frequently in solid organ transplant recipients than in the general population, according to researchers.
 

Bladder Cancer Survival Lowest in Blacks

November 01, 2011

Among patients with the malignancy, blacks are 29% more likely to die than whites, a study found.
 

Cystoscopy Alone is the Most Cost-Effective Way to Detect Bladder Cancer Recurrence

October 26, 2011

Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers.
 

Bladder Cancer Recurrence More Likely in Smokers

September 20, 2011

Smokers and ex-smokers who undergo transurethral resection of non-muscle-invasive bladder cancer (NMIBC) are at higher risk for disease recurrence compared with nonsmokers, according to new data.
 

Insufficient Evidence for Routine Bladder Cancer Screening

September 07, 2011

In an update to its 2004 guidance on screening for bladder cancer, the United States Preventive Services Task Force (USPSTF) has changed its recommendation from a D (lack of evidence) to an I (insufficient evidence) statement, finding inadequate data to support disease screening for asymptomatic adults or for adults with mild lower urinary tract symptoms such as urinary frequency, hesitancy, urgency, dysuria, or nocturia.
 

Data Back LNU for Upper Tract Urothelial-Cell Carcinoma

August 22, 2011

Laparoscopic and open nephroureterectomy for upper urinary tract urothelial-cell carcinoma (UUT-UCC), which are uncommon but aggressive malignancies, are associated with comparable long-term outcomes, Scottish investigators concluded.
 

Physicians Seldom Follow Bladder Cancer Guidelines

August 05, 2011

Physicians seldom following clinical guidelines for managing patients with high-grade, non-muscle-invasive bladder cancer, according to an online report in Cancer.
 

Pre-Cystectomy Smoking Linked to Worse Outcomes After Surgery

May 17, 2011

WASHINGTON, D.C.—Pre-cystectomy smoking habits influence survival following radical cystectomy for bladder cancer, according to researchers.
 

Lymph Node Density May Help Predict Bladder Cancer Death Risk

May 15, 2011

WASHINGTON, D.C.—Lymph node density (LN-density) may have prognostic relevance in patients with lymph node-positive bladder cancer (LNposBCA), according to a new German study presented at the American Urological Association 2011 annual meeting.
 

Robot-Assisted Radical Cystectomy Safe, Feasible for Octogenarians

May 15, 2011

WASHINGTON, D.C.—Robot-assisted radical cystectomy (RARC) is safe and feasible in octogenarians, researchers reported here at the American Urological Association 2011 annual meeting.
 

Induction BCG Sufficient for High-Risk NMIBC

May 05, 2011

Bacillus Calmette-Guérin (BCG) treatment without maintenance in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) compares favorably with trials in which comparable patients received maintenance BCG.
 

Cigarette Smoking More Strongly Linked to Invasive Bladder Cancer

April 18, 2011

Cigarette smoking is more strongly associated with an increased risk of invasive bladder cancer than with low-grade superficial bladder cancer, according to California researchers.
 

Drug May Be an Alternative to Cystectomy for BCG Failures

March 21, 2011

VIENNA—Mycobacterial cell wall DNA complex (MCC) may provide an alternative to cystectomy for patients with non-muscle invasive bladder cancer refractory to bacillus Calmette-Guérin (BCG) treatment, according to preliminary study findings.
 

Gene Test Predicts Bladder Cancer Spread

March 14, 2011

A gene test helped predict the risk of node-positive disease in patients with bladder disease so that beneficial neoadjuvant chemotherapy could be administered before cystectomy, researchers reported in Lancet Oncology (2011;12:137-143).
 

Blood Test Predicts Bladder Cancer Risk

March 14, 2011

A blood test can accurately detect biomolecular markers of bladder cancer resulting from environmental carcinogens, according to a study.
 

Ongoing Bladder Cancer Clinical Trials

 
 
 

Your Practice


Since its inception, health care providers have struggled with the need to protect patient privacy, share information, and keep paper work under control.

Read more on
Complying with HIPAA

Have any practice management topics that you'd like us to cover?
Let us know.

Legal Issues


Legal Issues

A primary care doctor referred a patient with an elevated PSA to a urologist. After a negative prostate biopsy, the doctor did not regularly conduct follow-up PSA testing, and the patient eventually died from prostate cancer.
Your Practice

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

Newsletters

Sign up to start receiving free e-newsletters from Renal & Urology News, including:

  • Latest CME
  • Ongoing Clinical Trials
  • Conference Highlights
  • Expert Q&A
  • Weekly Round-Up
Popular Topics
Acute Kidney Injury Anemia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Epidemiology Erectile Dysfunction Hemodialysis Hyperphosphatemia Hypertension Infection Kidney Cancer Kidney Stones Nutrition Overactive Bladder Peritoneal Dialysis Prostate Cancer PSA Reproductive Medicine Transplantation Urinary Incontinence UTI

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions